NemaGen Discoveries
Pre-clinicalNemaGen Discoveries is an early phase biotech company focused on advancing therapies for patients suffering from allergic inflammation and mast cell-related diseases.
Founded
2016
Focus
Small Molecules
About
NemaGen Discoveries is an early phase biotech company focused on advancing therapies for patients suffering from allergic inflammation and mast cell-related diseases.
Funding History
2Total raised: $5.5M
Seed$3MUndisclosedMay 15, 2021
Grant$2.5MNational Institutes of HealthOct 15, 2020
Company Info
TypePrivate
Founded2016
LocationIowa City, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile